ScholarIQanswers from OpenAlex

CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens

PaperCitations, authors & open-access status

CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens is a paper indexed in ScholarIQ from OpenAlex.

How many citations does CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens have?

ScholarIQcitation count

CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens has 32 citations in the OpenAlex counts ScholarIQ stores.

When was CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens published?

ScholarIQyear

CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens has 2017 year in the ScholarIQ index.

What is the open-access status of CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens?

ScholarIQoa status

CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens has gold oa status in the ScholarIQ index.

What is the DOI of CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens?

ScholarIQdoi

The DOI for CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens is on the source record.

What is the PMID of CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens?

ScholarIQpmid

The PMID for CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens is on the source record.

What is the OpenAlex record for CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens?

ScholarIQopenalex

The OpenAlex for CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial